Comparison of quality of life in patients with endometriosis undergoing treatment with progestins, oral contraceptives pills (OCP), and GnRH agonists
- PMID: 40836300
- PMCID: PMC12369266
- DOI: 10.1186/s12905-025-03937-3
Comparison of quality of life in patients with endometriosis undergoing treatment with progestins, oral contraceptives pills (OCP), and GnRH agonists
Abstract
Objective: The objective of this study was to compare the quality of life in patients with endometriosis undergoing treatment with progestins, OCPs, and GnRH agonists.
Methods: This prospective, observational, and comparative study was conducted on patients with endometriosis at Amir al-Momenin Hospital (Zabol, Iran) from 2022 to 2024. The Endometriosis Health Profile (EHP-30) questionnaire was used to utilized patients' quality of life.
Results: The study included three groups of women using OCPs, progestins, and GnRH agonists, consisting of 39, 74, and 22 participants, respectively. No significant differences were observed among the three groups with regard to occupation, education, marital status, physical activity, coffee consumption, or tobacco and alcohol use. However, a number of significant differences were identified in nutritional status, dyschezia, and psychological disorders. No statistically significant differences were observed in quality-of-life scores among the three groups (P = 0.197).
Conclusion: The three treatment approaches demonstrated comparable outcomes in terms of the quality of life of patients diagnosed with endometriosis. However, the observed differences in certain demographic and psychological health variables underscore the necessity to consider factors beyond pharmacological treatment to enhance the quality of life in these patients.
Keywords: Endometriosis; GnRH; OCP; Progestins; Quality of life.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Zabol University of Medical Sciences (Approval No. IR.ZBMU.REC.1404.010). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Oral contraceptives for pain associated with endometriosis.Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001019. doi: 10.1002/14651858.CD001019.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2018 May 22;5:CD001019. doi: 10.1002/14651858.CD001019.pub3. PMID: 17636650 Updated.
-
Endometriosis: an overview of Cochrane Reviews.Cochrane Database Syst Rev. 2014 Mar 10;2014(3):CD009590. doi: 10.1002/14651858.CD009590.pub2. Cochrane Database Syst Rev. 2014. PMID: 24610050 Free PMC article.
-
A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.Expert Opin Pharmacother. 2014 Apr;15(6):767-73. doi: 10.1517/14656566.2014.888414. Epub 2014 Mar 4. Expert Opin Pharmacother. 2014. PMID: 24588662
-
Gonadotropin-releasing hormone analogues for endometriosis.Cochrane Database Syst Rev. 2023 Jun 21;6(6):CD014788. doi: 10.1002/14651858.CD014788.pub2. Cochrane Database Syst Rev. 2023. PMID: 37341141 Free PMC article.
-
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2. Cochrane Database Syst Rev. 2013. PMID: 24234875 Free PMC article.
References
-
- Cano-Herrera G, Salmun Nehmad S, Ruiz de Chávez Gascón J, Méndez Vionet A, van Tienhoven XA, Osorio Martínez MF, et al. Endometriosis: A comprehensive analysis of the pathophysiology, treatment, and nutritional aspects, and its repercussions on the quality of life of patients. Biomedicines. 2024;12(7):1476. - PMC - PubMed
-
- Pašalić E, Tambuwala MM, Hromić-Jahjefendić A. Endometriosis: classification, pathophysiology, and treatment options. Pathology. 2023;251: 154847. - PubMed
-
- Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Reviews Endocrinol. 2019;15(11):666–82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical